Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
US Stock MarketDetailed Quotes
Redhill Biopharma (RDHL)
- 0.8130
- +0.0030+0.37%
Close Apr 15 16:00 ET
4.16MMarket Cap-0.29P/E (TTM)
0.8400High0.8100Low15.74KVolume0.8100Open0.8100Prev Close12.92KTurnover0.37%Turnover RatioLossP/E (Static)5.11MShares3.309952wk High-0.94P/B3.45MFloat Cap0.710152wk Low--Dividend TTM4.24MShs Float22220.0000Historical High--Div Yield TTM3.70%Range %0.7101Historical Low0.8206Avg Price1Lot Size
About Redhill Biopharma Company
RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment covers areas relating to commercial sales through a subsidiary in the United States. The Research and Development segment includes the study and licensing of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
Company Profile
SymbolRDHL
Company NameRedhill Biopharma
Listing DateDec 27, 2012
ISINUS7574683014
Founded2009
CEOMr. Dror Ben-Asher
MarketNASDAQ
Employees35
Securities TypeDR
ADS Ratio1 : 10000
Fiscal Year Ends12-31
Address21 Ha'arba'a Street
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6473921
Phone972-3-541-3131
Websitehttp://www.redhillbio.com
Company Executives
- Name
- Position
- Salary
- Dror Ben-Asher
- Chairman of the Board and Chief Executive Officer
- 566.47K
- Rick D. Scruggs
- Director and Chief Commercial Officer
- 443.74K
- Razi Ingber
- Chief Financial Officer
- 349.51K
- Guy Goldberg
- Chief Business Officer
- --
- Gilead Raday
- Chief Operating Officer
- 366.33K
- Adi Frish
- Chief Corporate and Business Development Officer
- 322.59K
- Dr. Reza Fathi, PhD
- Senior Vice President, Research and Development
- --
- Ofer Tsimchi
- Independent Director
- --
- Dr. Shmuel Cabilly
- Independent Director
- --
- Dr. Roni Mamluk, PhD
- Independent Director
- --
- Dr. Kenneth Reed
- Independent Director
- --
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However,
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm